Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Argatroban”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Testing effectiveness (Phase 2)Study completedNCT00861692
What this trial is testing

Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II

Who this might be right for
Heparin-induced Thrombocytopenia Type II
Tanabe Pharma Corporation 20
Post-approval studies (Phase 4)Study completedNCT03740958
What this trial is testing

Argatroban Plus R-tPA for Acute Ischemic Stroke

Who this might be right for
Stroke
General Hospital of Shenyang Military Region 808
Post-approval studies (Phase 4)Study completedNCT04275180
What this trial is testing

Efficacy Argatroban in Ischemic Stroke With Early Deterioration (EASE)

Who this might be right for
Acute Progressive Ischemic Stroke
Second Affiliated Hospital, Zhejiang University, School of Medicine 628
Early research (Phase 1)Study completedNCT05325346
What this trial is testing

A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects

Who this might be right for
Heparin-induced Thrombocytopenia
Veralox Therapeutics 12
Testing effectiveness (Phase 2)Ended earlyNCT01464788
What this trial is testing

Randomized Controlled Trial of Argatroban With Tissue Plasminogen Activator (tPA) for Acute Stroke

Who this might be right for
Ischemic Stroke
Andrew D. Barreto, MD 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07499037
What this trial is testing

Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO

Who this might be right for
PneumoniaHeart Failure
University Hospital Ostrava 200
Post-approval studies (Phase 4)Study completedNCT00035178
What this trial is testing

Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing Hemodialysis

Who this might be right for
Kidney Failure, ChronicRenal Disease, End-Stage
Texas Biotechnology Corporation 12
Testing effectiveness (Phase 2)Study completedNCT00268762
What this trial is testing

Argatroban Stroke Treatment - A Pilot Safety Study

Who this might be right for
Ischemic Stroke
The University of Texas Health Science Center, Houston 65
Post-approval studies (Phase 4)Study completedNCT00153946
What this trial is testing

Edaravone and Argatroban Stroke Therapy Study for Acute Ischemic Stroke

Who this might be right for
Stroke
Combination Therapy for Acute Ischemic Stroke Study Group 814
Post-approval studies (Phase 4)Looking for participantsNCT06442267
What this trial is testing

Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support

Who this might be right for
Respiratory InsufficiencyCirculatory FailureThromboembolism+1 more
Medical University of Vienna 90
Post-approval studies (Phase 4)Study completedNCT00039858
What this trial is testing

Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin

Who this might be right for
ThrombocytopeniaThrombosis
Encysive Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT02448069
What this trial is testing

Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke

Who this might be right for
StrokeCerebral Ischemia
The University of Texas Health Science Center, Houston 10
Large-scale testing (Phase 3)Study completedNCT02935530
What this trial is testing

Thromboprophylaxis After Surgery for Gynecologic Malignancy in China

Who this might be right for
Gynecologic NeoplasmsVenous ThromboembolismLow Molecular Weight Heparin+1 more
Huazhong University of Science and Technology 315
Testing effectiveness (Phase 2)Study completedNCT00508924
What this trial is testing

Study on Safety and Effectiveness of Three Doses of Argatroban as Anticoagulant in Percutaneous Coronary Intervention (PCI)

Who this might be right for
Coronary Artery DiseaseAngina, Unstable
Tanabe Pharma Corporation 140
Not applicableStudy completedNCT06038682
What this trial is testing

Monitoring Anticoagulation in Patients on ECMO for Severe Lung Failure

Who this might be right for
ARDSCOVID-19
University Hospital Ostrava 100
Post-approval studies (Phase 4)Ended earlyNCT00798525
What this trial is testing

Argatroban Versus Lepirudin in Critically Ill Patients

Who this might be right for
Heparin Induced Thrombocytopenia (HIT)
Heinrich-Heine University, Duesseldorf 70
Post-approval studies (Phase 4)Study completedNCT01163604
What this trial is testing

Argatroban for Preventing Occlusion and Restenosis After Intracranial and Extracranial Artery Stenting

Who this might be right for
CVD
Jinling Hospital, China 114
Large-scale testing (Phase 3)Study completedNCT05226442
What this trial is testing

Safety and Feasibility of Argatroban As Anticoagulant in Adults with ECMO

Who this might be right for
Extracorporeal Membrane Oxygenation ComplicationAnticoagulants and Bleeding Disorders
Medical University of Vienna 40
Not applicableUnknownNCT06066762
What this trial is testing

Argatroban Monitoring in Acute Suspected Heparin-induced Thrombocytopenia.

Who this might be right for
Heparin-induced Thrombocytopenia
Assistance Publique - Hôpitaux de Paris 200
Not applicableLooking for participantsNCT07302620
What this trial is testing

HEPARINS: INTERFERENCE IN ARGATROBAN MEASUREMENT

Who this might be right for
Thromboembolic Disease
University Hospital, Strasbourg, France 70
Next Page